About You Holding AG Stock
Price
Target price
€4.89
€4.89
2.880%
0.135
2.880%
€5.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
About You Holding AG Stock
There is an upward development for About You Holding AG compared to yesterday, with an increase of €0.14 (2.880%).
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the About You Holding AG stock is not clear.
With a target price of €5.00 there is a slightly positive potential of 2.249% for About You Holding AG compared to the current price of €4.89.
Our community identified positive and negative aspects for About You Holding AG stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the About You Holding AG stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.
Pros and Cons of About You Holding AG in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
News
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: ABOUT YOU Holding SE: ABOUT YOU Delivers Solid Growth in Q3 2022/2023 despite Continued Market Volatility
EQS-News: ABOUT YOU Holding SE: SCAYLE wins new customers with a sales volume of around EUR 100 million in 2022
EQS-News: ABOUT YOU Holding SE: SCAYLE wins new customers with a sales volume of around EUR 100 million in 2022
EQS-News: ABOUT YOU Holding SE: ABOUT YOU delivers robust Q2 2022/2023 results and confirms full-year guidance
EQS-News: ABOUT YOU Holding SE: ABOUT YOU delivers robust Q2 2022/2023 results and confirms full-year guidance
